Browse Category

Financial Updates News 5 December 2025 - 8 December 2025

Protara Therapeutics (TARA) Stock Plunges After $75 Million Offering: Latest Trial Data, Analyst Targets and Outlook as of December 5, 2025

Protara Therapeutics (TARA) Stock Plunges After $75 Million Offering: Latest Trial Data, Analyst Targets and Outlook as of December 5, 2025

Published: December 5, 2025 Protara Therapeutics, Inc. (NASDAQ: TARA) is ending the week in dramatic fashion. After a string of positive clinical updates for its lead cell therapy TARA‑002, the company has tapped equity markets with a $75 million public
Argan (AGX) Stock: Q3 2026 Earnings Beat, Record $3 Billion Backlog and What December 4, 2025 Means for the Forecast

Argan (AGX) Stock: Q3 2026 Earnings Beat, Record $3 Billion Backlog and What December 4, 2025 Means for the Forecast

Published: December 4–5, 2025 | Ticker: NYSE: AGX Argan, Inc. (AGX) just delivered another strong quarter – and the market promptly punished the stock after hours. On December 4, 2025, the engineering and construction group reported fiscal Q3 2026 results
1 2 3 4 5 13
Go toTop